RL vs STRO
Ralph Lauren Corp Class A (RL) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported RL revenue for 2025-03-29 was $7.08B. Net income was $742.9M. Revenue was up 6.7% from 2024-03-30 to 2025-03-29. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
RL currently screens at market cap $16.95B and trailing P/E 24.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the RL and STRO stock pages for the full models.
Not investment advice.